146 related articles for article (PubMed ID: 35364741)
1. Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson's disease.
Gschmack E; Monoranu CM; Marouf H; Meyer S; Lessel L; Idris R; Berg D; Maetzler W; Steigerwald F; Volkmann J; Gerlach M; Riederer P; Koutsilieri E; Scheller C
J Neural Transm (Vienna); 2022 Jun; 129(5-6):545-555. PubMed ID: 35364741
[TBL] [Abstract][Full Text] [Related]
2. Enteric GFAP expression and phosphorylation in Parkinson's disease.
Clairembault T; Kamphuis W; Leclair-Visonneau L; Rolli-Derkinderen M; Coron E; Neunlist M; Hol EM; Derkinderen P
J Neurochem; 2014 Sep; 130(6):805-15. PubMed ID: 24749759
[TBL] [Abstract][Full Text] [Related]
3. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.
Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ
Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022
[TBL] [Abstract][Full Text] [Related]
4. Effects of eldepryl on glial cell proliferation and activation in the substantia nigra and striatum in a rat model of Parkinson's disease.
Liu B; Lv C; Zhang J; Liu Y; Sun J; Cheng X; Mao W; Ma Y; Li S
Neurol Res; 2017 May; 39(5):459-467. PubMed ID: 28276259
[TBL] [Abstract][Full Text] [Related]
5. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.
Venkateshappa C; Harish G; Mythri RB; Mahadevan A; Bharath MM; Shankar SK
Neurochem Res; 2012 Feb; 37(2):358-69. PubMed ID: 21971758
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease.
Gómez-Gálvez Y; Fuller HR; Synowsky S; Shirran SL; Gates MA
J Neurosci Res; 2020 Jul; 98(7):1417-1432. PubMed ID: 32270889
[TBL] [Abstract][Full Text] [Related]
7. Identification of autoantibodies to glial fibrillary acidic protein in spinal cord injury patients.
Hergenroeder GW; Moore AN; Schmitt KM; Redell JB; Dash PK
Neuroreport; 2016 Jan; 27(2):90-3. PubMed ID: 26629661
[TBL] [Abstract][Full Text] [Related]
8. Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension.
Yetimler B; Tzartos J; Şengül B; Dursun E; Ulukan Ç; Karagiorgou K; Gezen-Ak D; Sezgin M; Papaconstantinou A; Tzartos S; Orhan EK; Ekizoğlu E; Küçükali Cİ; Baykan B; Tüzün E
Int J Neurosci; 2021 Aug; 131(8):775-779. PubMed ID: 32303142
[TBL] [Abstract][Full Text] [Related]
9. [Effects of
Wang Q; Liu Z; Wang Y; Li J; Lu G; Jing Z; Liu Y; Guo Y
Zhongguo Zhen Jiu; 2018 Oct; 38(10):1093-7. PubMed ID: 30672240
[TBL] [Abstract][Full Text] [Related]
10. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
[TBL] [Abstract][Full Text] [Related]
11. Glial fibrillary acidic protein (GFAP) and anti-GFAP autoantibody in canine necrotising meningoencephalitis.
Toda Y; Matsuki N; Shibuya M; Fujioka I; Tamahara S; Ono K
Vet Rec; 2007 Aug; 161(8):261-4. PubMed ID: 17720962
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach.
Biswas S; Sharma S; Saroha A; Bhakuni DS; Malhotra R; Zahur M; Oellerich M; Das HR; Asif AR
PLoS One; 2013; 8(2):e56246. PubMed ID: 23418544
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin (orexin) cell loss in Parkinson's disease.
Thannickal TC; Lai YY; Siegel JM
Brain; 2007 Jun; 130(Pt 6):1586-95. PubMed ID: 17491094
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune glial fibrillary acidic protein astrocytopathy associated with breast cancer: a case report.
Yaguchi T; Kimura A; Takekoshi A; Matsuo M; Tomita H; Shimohata T
BMC Neurol; 2023 Apr; 23(1):145. PubMed ID: 37016352
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody to glial fibrillary acidic protein in the sera of cattle with bovine spongiform encephalopathy.
Nomura S; Miyasho T; Maeda N; Doh-ura K; Yokota H
Proteomics; 2009 Aug; 9(16):4029-35. PubMed ID: 19658106
[TBL] [Abstract][Full Text] [Related]
16. Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides.
Torres-Platas SG; Nagy C; Wakid M; Turecki G; Mechawar N
Mol Psychiatry; 2016 Apr; 21(4):509-15. PubMed ID: 26033239
[TBL] [Abstract][Full Text] [Related]
17. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis.
Shibuya M; Matsuki N; Fujiwara K; Imajoh-Ohmi S; Fukuda H; Pham NT; Tamahara S; Ono K
J Vet Med Sci; 2007 Mar; 69(3):241-5. PubMed ID: 17409638
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell-based and tissue-based immunofluorescent assays for detection of glial fibrillary acidic protein autoantibodies in the cerebrospinal fluid of dogs with meningoencephalitis of unknown origin and other central nervous system disorders.
Rozental AJ; McGrath S; Mooney AP; Hinson SR; McKeon A; Pittock SJ; Gross CC; Tyler KL
Am J Vet Res; 2021 Feb; 82(2):132-137. PubMed ID: 33480282
[TBL] [Abstract][Full Text] [Related]
20. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
